论文部分内容阅读
目的:探讨护肝片对药物性肝损害的治疗及其预防效果。方法:选取60例进行抗结核病治疗的患者,随机分为观察组及对照组,每组30例。治疗期间治疗组给予护肝片结合治疗,对照组给予肌苷片治疗。结果:治疗期间,治疗组中肝功能受损为3例,受损率为10%,对照组中肝功能受损为7例,受损率23.33%,治疗组患者在治疗2周后只有3例出现ALT异常,而对照组中7例,再经治疗4周后,治疗组中肝功能均正常,对照组仍有3例肝功能异常,其差异具有统计学上意义(P<0.05)。结论:护肝片可有效地治疗及预防药物性的肝损害,在进行损肝药物治疗的过程中,可配合使用,以降低肝的损害程度。
Objective: To investigate the treatment and prevention of drug-induced liver damage by Hugan Tablets. Methods: Sixty patients with anti-tuberculosis treatment were randomly divided into observation group and control group, 30 cases in each group. During treatment, the treatment group was treated with Hugan tablet and the control group with inosine tablets. Results: During the treatment period, the liver function in the treatment group was impaired in 3 cases and the damage rate was 10%. In the control group, the impaired hepatic function was 7 and the damage rate was 23.33%. In the treatment group, only 3 In the control group, 7 cases had ALT abnormalities. After 4 weeks of treatment, the liver function of the treatment group was normal. There were still 3 cases of liver dysfunction in the control group. The difference was statistically significant (P <0.05). Conclusion: Hugan tablet can effectively treat and prevent drug-induced liver damage. It can be used in conjunction with liver damage medication to reduce the degree of liver damage.